Stocks and Investing
Stocks and Investing
Wed, February 28, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tyler Bussian Downgraded (ANVS) to Hold and Held Target at $9 on, Feb 28th, 2024
Tyler Bussian of Brookline Capital, Downgraded "Annovis Bio, Inc." (ANVS) to Hold and Held Target at $9 on, Feb 28th, 2024.
Tyler has made no other calls on ANVS in the last 4 months.
There are 2 other peers that have a rating on ANVS. Out of the 2 peers that are also analyzing ANVS, 0 agree with Tyler's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Tyler
- Sumant Kulkarni of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $36 on, Friday, December 29th, 2023
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $30 on, Tuesday, November 28th, 2023
Contributing Sources